ReviewInternational ophthalmology2026
Pathological mechanisms of Sjögren's disease-related dry eye: from multiglandular dysfunction to ocular surface inflammation.
Review in International ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Sjögren's disease-related dry eye (SjD‑DE) refers to a form of dry eye disease driven by autoimmune dysregulation in Sjögren's disease (SjD). Compared with primary dry eye, patients with SjD-DE typically present with more pronounced symptoms and signs, along with persistent and refractory disease courses that markedly impair daily functioning and quality of life. Although the precise mechanisms underlying SjD-DE have not been fully elucidated, accumulating evidence indicates that SjD affects not only lacrimal secretion but also multiple components of the ocular surface. In this context, we review recent pathological studies focusing on glandular dysfunction, goblet cell loss, tear film hyperosmolarity, ocular surface inflammation, and corneal nerve pathology in SjD-DE. These pathological alterations are highly interconnected and mutually reinforcing, ultimately driving the "vicious cycle" of ocular surface damage. This review aims to provide insights to support the development of novel non-invasive diagnostic criteria and future therapeutic strategies for SjD-DE.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.